| | |
Xience V
|
Taxus
|
|---|
|
Strut/IEL gap
|
Incidence
|
1/11
|
7/11
|
| |
Percentage
|
5.6
|
36.9 ± 32.9
|
|
Peri-strut hemorrhage
|
Incidence
|
------
|
2/11
|
| |
Percentage
|
------
|
11.3 ± 10.7
|
|
Peri-strut plasma
|
Incidence
|
11/11
|
3/11
|
| |
Grade
|
1.35 ± 20.6
|
0.78 ± 0.39
|
|
Marginated/subendothelial leukocytes
|
Incidence
|
4/11
|
10/11
|
| |
Grade
|
0.46 ± 0.16
|
1.00 ± 0.52
|
|
Neointimal neovascularization
|
Incidence
|
------
|
5/11
|
| |
Grade
|
------
|
0.80 ± 0.18
|
|
Medial necrosis
|
Incidence
|
------
|
7/11
|
| |
Grade
|
------
|
0.52 ± 0.26
|
|
Adventitial inflammation
|
Incidence
|
------
|
1/11
|
| |
Grade
|
------
|
0.33
|
|
Adventitial fibrosis
|
Incidence
|
------
|
------
|
| |
Grade
|
------
|
------
|
- Incidence results are presented as # of stents with findings/total number of stents.
- Mean grade or percentage results are presented as mean grade or percentage of affected struts per group ± standard deviation.
- n = 11 for Xience V, n = 11 for Taxus.
